Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 561
- Registration Number
- NCT00545090
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 417
- Registration Number
- NCT00545688
- Locations
- 🇦🇺
Geelong Hospital; Andrew Love Cancer Centre, Geelong, Victoria, Australia
🇲🇽ARKE Estudios Clínicos S.A. de C.V., Mexico City, Mexico
🇮🇱Meir Medical Center; Oncology, Kfar-Saba, Israel
MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 120
- Registration Number
- NCT00545571
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 132
- Registration Number
- NCT00535782
- Locations
- 🇺🇸
Rheumatology Associates of North Alabama, Huntsville, Alabama, United States
🇺🇸Pinnacle Research Group; Llc, Central, Anniston, Alabama, United States
🇺🇸Arthritis & Rheumatism; Disease Specialities, Aventura, Florida, United States
A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas
- First Posted Date
- 2007-09-21
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT00532948
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
- Conditions
- Lymphocytic Leukemia, Chronic
- Interventions
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 100
- Registration Number
- NCT00532129
A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2014-11-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 124
- Registration Number
- NCT00531960
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 60
- Registration Number
- NCT00531804
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2012-08-20
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 619
- Registration Number
- NCT00531817
A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 110
- Registration Number
- NCT00532090